PATENT CLAIM ANALYSIS

Application Number: 15910322
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-07
Patent Classification: ["514", "04400A"]

Abstract:
A composition is provided that comprises a therapeutic agent encapsulated by a milk-derived microvesicle. The compositions can include therapeutic agents such as phytochemical agents or chemotherapeutic agents, while the milk-derived microvesicle can be derived from raw milk or colostrum. Further provided are methods for isolating a microvesicle that includes the steps of obtaining an amount of milk, and subjecting the milk to a series of sequential centrifugations configured to yield greater than about 300 mg of microvesicle protein per 100 ml of milk. Methods of modifying an immune response and treating a cancer in which a milk-derived microvesicle composition is administered are also provided.

Claim (Index 11):
The composition of  claim 1  wherein the chemotherapeutic agent is a selective estrogen receptor modulator selected from tamoxifen, toremifene, droloxifene, faslodex, raloxifene or combinations thereof.

Metadata:
- Claim Count in Document: 21.0
- Percentile: 90.0
- Lexical Diversity: 1.5493
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14770634', '14825957', '14438172', '15458552', '15257669']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7929629899518397
- 35 USC 102 Novelty (BERT): 0.6190015038552773
- Combined Prediction Score: 0.7755668413421835
- Mean Citation Score: 393.542248
- Max Citation Score: 777.15063
- Similarity Product: 482.2808627704632

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test